pubmed-article:16306800 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0082428 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C2825032 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C1958507 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
pubmed-article:16306800 | lifeskim:mentions | umls-concept:C1637379 | lld:lifeskim |
pubmed-article:16306800 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:16306800 | pubmed:dateCreated | 2005-11-24 | lld:pubmed |
pubmed-article:16306800 | pubmed:abstractText | Heart failure after myocardial infarction (MI) is associated with endothelial dysfunction. There is conflicting evidence on the exact nature of this endothelial dysfunction and how endothelium-dependent vasodilation is affected by angiotensin-converting enzyme inhibitor (ACE-I) therapy. Furthermore, consequences of acute ACE-I withdrawal are largely unknown. Therefore, we studied the contribution of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) to the effects of ACE-I therapy and its withdrawal on endothelial function in MI rats. Rats were subjected to coronary ligation to induce MI and were assigned to quinapril or vehicle from 2 weeks to 8 months post-MI. In parallel, MI rats treated for 14 months with quinapril were subjected to treatment withdrawal for 0, 4, and 6 weeks. Acetylcholine (ACh)-induced relaxation and underlying endothelium-derived mediators were studied in isolated aortic rings. Long-term quinapril (8 months) resulted in markedly improved endothelium-dependent vasodilation in rats with myocardial infarction, which could be attributed to marked improvement in non-NO/prostanoid-mediated relaxation (ie, EDHF). After 14 months of follow-up, maximum vasodilation was still preserved by quinapril. Withdrawal after 14 months of treatment caused significantly impaired ACh-induced EDHF-mediated relaxation within 4 weeks. A marked reduction in EDHF-mediated relaxation caused this impairment. NO-mediated relaxation was unaffected. These findings highlight the importance of EDHF impairment in development of endothelial dysfunction after myocardial infarction and the possibility of improving EDHF-mediated vasodilation with chronic ACE inhibitor therapy. In addition, withdrawal of chronic ACE inhibition after MI should be considered carefully, as profound endothelial dysfunction may develop rapidly. | lld:pubmed |
pubmed-article:16306800 | pubmed:language | eng | lld:pubmed |
pubmed-article:16306800 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16306800 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16306800 | pubmed:month | Dec | lld:pubmed |
pubmed-article:16306800 | pubmed:issn | 0160-2446 | lld:pubmed |
pubmed-article:16306800 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:16306800 | pubmed:author | pubmed-author:BuikemaHendri... | lld:pubmed |
pubmed-article:16306800 | pubmed:author | pubmed-author:SchoemakerReg... | lld:pubmed |
pubmed-article:16306800 | pubmed:author | pubmed-author:WestendorpBar... | lld:pubmed |
pubmed-article:16306800 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16306800 | pubmed:volume | 46 | lld:pubmed |
pubmed-article:16306800 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16306800 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16306800 | pubmed:pagination | 766-72 | lld:pubmed |
pubmed-article:16306800 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:meshHeading | pubmed-meshheading:16306800... | lld:pubmed |
pubmed-article:16306800 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16306800 | pubmed:articleTitle | Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction. | lld:pubmed |
pubmed-article:16306800 | pubmed:affiliation | Department of Clinical Pharmacology, University Medical Center, Groningen, The Netherlands. b.westendorp@med.umcg.nl | lld:pubmed |
pubmed-article:16306800 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16306800 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |